Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Steven G. Chrysant. (2011) Single-Pill Triple-Combination Therapy: An Alternative to Multiple-Drug Treatment of Hypertension. Postgraduate Medicine 123:6, pages 21-31.
Read now
Read now
Johannes Schweizer, Hans-Joachim Ulmer, Henning Benduhn & Sven Klebs. (2011) Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (±amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg. Current Medical Research and Opinion 27:1, pages 131-140.
Read now
Read now
Carlos M Ferrario & Ronald D Smith. (2010) Role of olmesartan in combination therapy in blood pressure control and vascular function. Vascular Health and Risk Management 6, pages 701-709.
Read now
Read now
Articles from other publishers (7)
Natalie Timme, Youjia Han, Shuai Liu, Hailemichael O. Yosief, Heathcliff Dorado García, Yi Bei, Filippos Klironomos, Ian C. MacArthur, Annabell Szymansky, Jennifer von Stebut, Victor Bardinet, Constantin Dohna, Annette Künkele, Jana Rolff, Patrick Hundsdörfer, Andrej Lissat, Georg Seifert, Angelika Eggert, Johannes H. Schulte, Wei Zhang & Anton G. Henssen. (2020) Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors. Translational Oncology 13:2, pages 221-232.
Crossref
Crossref
Jens-Uwe Peters. (2013) Polypharmacology – Foe or Friend?. Journal of Medicinal Chemistry 56:22, pages 8955-8971.
Crossref
Crossref
Andrew J. Lewin, Joseph L. IzzoJrJr, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2013) Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age. Drugs & Aging 30:7, pages 549-560.
Crossref
Crossref
Dean J Kereiakes, Steven G Chrysant, Joseph L IzzoJrJr, Thomas LittlejohnIIIIII, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2012) Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study. Cardiovascular Diabetology 11:1.
Crossref
Crossref
Dean J. Kereiakes, Steven G. Chrysant, Joseph L. IzzoJrJr, Thomas LittlejohnIIIIII, Suzanne Oparil, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2012) Long‐Term Efficacy and Safety of Triple‐Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension. The Journal of Clinical Hypertension 14:3, pages 149-157.
Crossref
Crossref
Howard S Weintraub & Amy Rudolph. (2011) Combination Therapy for Managing Difficult-to-Treat Patients With Stage 2 Hypertension: Focus on Valsartan-Based Combinations. American Journal of Therapeutics 18:6, pages e227-e243.
Crossref
Crossref
James E. Frampton & Lesley J. Scott. (2009) Amlodipine/Valsartan Single-Pill Combination. American Journal Cardiovascular Drugs 9:5, pages 309-330.
Crossref
Crossref